The already raging coronavirus pandemic has got a shot in the arm with the tiny particle, the virus, presenting with genetic variant forms of epidemiological significance. This has posed numerous challenges in front of the scientific community with its potentially multi-faceted impacts on the clinical presentations, efficacy and accuracy of available diagnostics and also the effectiveness of the vaccines.
The key to manage the “variant outbreak” would be the “pace” at which these could be identified, and their impact characterized across the diagnostic, therapeutic, and preventive aspects of the disease. This certainly needs some of the most advanced research applied globally at a significant pace.
While the world struggles with the pandemic management, there lies hope in the efforts of science and researchers around the globe that human innovation could outpace and outsmart the virus.’
Read our latest article on how public health organizations, researchers and government agencies are collaborating to ensure that they keep pace up with mutant identification vis a vis vaccine effectiveness and ultimately a herd immunity is achieved through mass vaccination